Inhaled Corticosteroids in COPD and Bronchiectasis
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive SummaryEuropean Respiratory Journal, 2023
- Endotyping Chronic Obstructive Pulmonary Disease, Bronchiectasis, and the “Chronic Obstructive Pulmonary Disease–Bronchiectasis Association”American Journal of Respiratory and Critical Care Medicine, 2022
- Characterization of Eosinophilic Bronchiectasis: A European Multicohort StudyAmerican Journal of Respiratory and Critical Care Medicine, 2022
- Neutrophil extracellular traps, disease severity, and antibiotic response in bronchiectasis: an international, observational, multicohort studyThe Lancet Respiratory Medicine, 2021
- The sputum microbiome, airway inflammation, and mortality in chronic obstructive pulmonary diseaseJournal of Allergy and Clinical Immunology, 2021
- Introduction to precision medicine in COPDEuropean Respiratory Journal, 2019
- The overlap between bronchiectasis and chronic airway diseases: state of the art and future directionsEuropean Respiratory Journal, 2018
- Long-term effects of inhaled corticosteroids on sputum bacterial and viral loads in COPDEuropean Respiratory Journal, 2017
- European Respiratory Society guidelines for the management of adult bronchiectasisEuropean Respiratory Journal, 2017
- Salmeterol and Fluticasone Propionate and Survival in Chronic Obstructive Pulmonary DiseaseNew England Journal of Medicine, 2007